Medical specialists from Korea, Republic of tagged as investigators in clinical trials studying Polycythemia Vera
Total 13 results
-
Byung SooSeen in:
- Seoul, Korea University Anam Hospital
Trials:- NCT04603495 (Principal Investigator)
-
Chong So YoungSeen in:
- Gyeonggi-do, Cha Bundang Medical Center Cha University
Trials:- NCT04603495 (Principal Investigator)
-
Chui-Won ChoiSeen in:
- Seoul, Korea University Guro Hospital
Trials:- NCT04603495 (Principal Investigator)
-
Chul-Won JungSeen in:
- Seoul, Samsung Medical Center
Trials:- NCT04603495 (Principal Investigator)
-
Ho Jin ShinSeen in:
- Busan, Pusan National University Hospital
- Pusan-Kwangyǒkshi, Busan, Pusan National University Hospital
Trials:- NCT04666038 (Principal Investigator)
- NCT04603495 (Principal Investigator)
-
Jae-Yong KwakSeen in:
- Jeollabuk-do, Jeonju, Chonbuk National University Hospital
- Jeonju, Jeonbuk National University Hospital
- Other, Jeonju-Si, Jeonbuk National University Hospital
Trials:- NCT03589326 (Principal Investigator)
- NCT04603495 (Principal Investigator)
- NCT04404283 (Principal Investigator)
-
Jeong KimSeen in:
- Gyeonggi-do, The Catholic University of Korea St. Vincent Hospital
Trials:- NCT04603495 (Principal Investigator)
-
June Won CheongSeen in:
- Seoul, Severance Hospital, Yonsei University Health System
Trials:- NCT04603495 (Principal Investigator)
-
Sukjoong OhSeen in:
- Seoul, Hanyang University Medical Center
Trials:- NCT04603495 (Principal Investigator)
-
Sung Hwa BaeSeen in:
- Daegu, Daegu Catholic University Medical Center
Trials:- NCT04603495 (Principal Investigator)
-
Sung-Eun LeeSeen in:
- Seoul, The Catholic University of South Korea Seoul St. Mary's Hospital
Trials:- NCT04603495 (Principal Investigator)
-
Sungnam LimSeen in:
- Busan, Inje university Haeundae Paik Hospital
Trials:- NCT04603495 (Principal Investigator)
-
YooJin LeeSeen in:
- Ulsan, Ulsan University Hospital
Trials:- NCT04603495 (Principal Investigator)
Clinical Trials on Polycythemia Vera
-
PharmaEssentia Japan K.K.RecruitingPolycythemia Vera (PV)Japan
-
Novartis PharmaceuticalsCompletedPolycythemia Vera (PV)United States
-
PharmaEssentia Japan K.K.Recruiting
-
PharmaEssentia Japan K.K.CompletedPolycythemia Vera (PV)Japan
-
Ionis Pharmaceuticals, Inc.RecruitingPhlebotomy Dependent Polycythemia VeraUnited States, Canada, Hungary, United Kingdom, Australia, Poland
-
Memorial Sloan Kettering Cancer CenterEli Lilly and Company; Incyte CorporationRecruitingMyelofibrosis Due to and Following Polycythemia VeraUnited States
-
Northwestern UniversityNational Cancer Institute (NCI); Celgene; The Leukemia and Lymphoma SocietyWithdrawnPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis PhaseUnited States
-
Novartis PharmaceuticalsTerminatedPrimary Myelofibrosis | Post-Polycythemia Vera | Post-Essential ThrombocytopeniaUnited States
-
CelgeneRecruitingPrimary Myelofibrosis | Myeloproliferative Disorders | Anemia | Myelofibrosis | Post-Polycythemia Vera MyelofibrosisFrance, Belgium, Spain, Australia, Canada, United States, Korea, Republic of, Romania, Japan, Israel, Italy, Austria, China, Czechia, Germany, Greece, Ireland, Poland, United Kingdom, Hong Kong, Hungary, Lebanon, Argentina, Chile, Colombia and more
-
CelgeneImpact Biomedicines, Inc., a wholly owned subsidiary of Celgene CorporationActive, not recruitingPrimary Myelofibrosis | Myelofibrosis | Post-Polycythemia VeraAustralia, Austria, Belgium, China, Czechia, France, Germany, Hungary, Italy, Korea, Republic of, Netherlands, Poland, Russian Federation, Spain, Ireland, United Kingdom